Ceylinco Healthcare Services Limited (CHSL) Chairman R. Renganathan and Apollo Hospitals Chairman Dr. Prathap Reddy (centre) exchange the agreement in the presence of Prof. Rohan Jayasekera, Medical Director CHSL, CHSL Director Thushara Ranasinghe and General Manager MrTharuka De Silva.
Proton Therapy, the most advanced form of radiation treatment available in the world, has become more accessible and affordable for cancer patients in Sri Lanka following the appointment of Ceylinco Healthcare Services Limited (CHSL) as a Medical Affiliate of Apollo Hospitals Enterprise Limited (AHEL) of India, which operates the Apollo Proton Cancer Centre in Chennai, the first and only Proton Therapy facility in the South East Asian region.
Announcing the milestone and the enrolment of CHSL in the Apollo Proton Partners Network Initiative, the Company said patients undergoing treatment at CHSL’s two radiation treatment centres in Colombo can now be referred to the Apollo Proton Cancer Centre in Chennai if proton therapy is recommended, and undergo treatment at a preferred partner program specified under the agreement between the two institutions.
Over the last decade, Proton Therapy has gained tremendous momentum globally due to its superior dose distribution and minimal side effects. It is increasingly being used to treat cancers, particularly those where treatment options are limited, or conventional radiation therapy presents risks to patients, as well as form any childhood cancers, due to these unique advantages.
The Apollo Proton Cancer Centre in Chennai is the most advanced cancer care centre with pencil beam technology and the ability to deliver intensity modulated proton therapy (IMPT) image-guided and patient positioning systems, and is aided by the most sophisticated proton treatment planning systems.
“We already offer advanced radiation oncology in Sri Lanka via Tomo Therapy and Linear Accelerator ensuring patients have the latest and most comprehensive treatment at the most affordable price,” CHSL Chairman Mr R. Renganathan said.“We are not providing proton therapy currently or in the near future, and therefore decided to partner with APCC and provide access to patients who will need this form of treatment.”
“We are pleased to have entered into a clinical partnership with Ceylinco Healthcare as part of the access to proton therapy programme at Apollo Proto Cancer Centre.Patients that would benefit from Proton therapy will now be able to access the most advanced care cancer centre and thus strengthen their battle against cancer and improve their quality of life,” Mr Dinesh Madhavan, President, Group Oncology and International at AHEL said.
A ‘Proton Collaboration Agreement’ entered into by Ceylinco Healthcare Services and Apollo Hospitals Enterprise in October 2019 paves the way for the two institutions to collaborate seamlessly in evaluating patient requirements, referrals to the Apollo Proton Cancer Centre for treatment and post treatment care.
The Apollo Proton Partners Network Initiative of which CHSL is now a member also has provision for Apollo specialists to work with physicians, consult and share resources to complement physician expertise at partner companies.
0 comments: